Skip to main content

Articles

Page 4 of 17

  2. Deep vein thrombosis (DVT) is a common complication in cancer. Although thromboprophylaxis in cancer patients is recommended by the guidelines, clinicians’ use of thromboprophylaxis remains limited due to cost...

    Authors: Budi Setiawan, Widi Budianto, Tri Wahyu Sukarnowati, Daniel Rizky, Eko Adhi Pangarsa, Damai Santosa, Aru Wisaksono Sudoyo, Tri Indah Winarni, Ignatius Riwanto, Rahajuningsih Dharma Setiabudy and Catharina Suharti
    Citation: Thrombosis Journal 2023 21:54
    Content type: Research Published on:

  5. Pulmonary embolism (PE) is an important complication of Coronavirus disease 2019 (COVID-19). COVID-19 is associated with respiratory impairment and a pro-coagulative state, rendering PE more likely and difficu...

    Authors: Jakob Vielhauer, Christopher Benesch, Anna Pernpruner, Anna-Lena Johlke, Johannes Christian Hellmuth, Maximilian Muenchhoff, Clemens Scherer, Nicola Fink, Bastian Sabel, Christian Schulz, Julia Mayerle, Ujjwal Mukund Mahajan and Hans Christian Stubbe
    Citation: Thrombosis Journal 2023 21:51
    Content type: Research Published on:

  6. It remains unknown whether anticoagulation for persistent left ventricular (LV) thrombus should be continued indefinitely. Identifying patients with a high risk of thrombus unresolved may be helpful to determi...

    Authors: Qing Yang, Xin Quan, Chuangshi Wang, Litian Yu, Yanmin Yang, Jun Zhu and Yan Liang
    Citation: Thrombosis Journal 2023 21:50
    Content type: Research Published on:

  7. There is room for improvement of prevention of venous thromboembolism (VTE) after lower-leg cast application or knee arthroscopy. Information about the mechanism of clot formation in these patients may be usef...

    Authors: Carolina E. Touw, Banne Nemeth, Raymond A. van Adrichem, Astrid van Hylckama Vlieg, Rob G. H. H. Nelissen, Ton Lisman and Suzanne C. Cannegieter
    Citation: Thrombosis Journal 2023 21:49
    Content type: Research Published on:

  9. The first case of Vaccine-Induced Thrombotic Thrombocytopenia (VITT) was reported in the letter-to-editor submission in the journal of Indian Journal of Hematology and Blood Transfusion which was published onl...

    Authors: Jyoti Kotwal and K. V. Vinu Balraam
    Citation: Thrombosis Journal 2023 21:47
    Content type: Correspondence Published on:

    The original article was published in Thrombosis Journal 2022 20:11

    The Response to this article has been published in Thrombosis Journal 2023 21:48

  10. There are very few documented reports in literature of cerebral venous sinus thrombosis (CVST) caused by immune-mediated heparin-induced thrombocytopenia (HIT). Further, there are very few reports of false neg...

    Authors: Floyd D. Silva, Allison E. Burnett, Anand Padmanabhan, Marian A. Rollins-Raval, Noah P. Splinter and Masoom J. Desai
    Citation: Thrombosis Journal 2023 21:46
    Content type: Case Report Published on:

  11. Patients with venous anomalies are at increased risk of developing venous thromboembolism (VTE) and subsequent complications, but they are often under-recognised. While unprovoked VTE may trigger testing for i...

    Authors: Caroline Dix, Warren Clements, Harry Gibbs, Joanne So, Huyen A Tran and James D McFadyen
    Citation: Thrombosis Journal 2023 21:45
    Content type: Review Published on:

  13. Atypical hemolytic uremic syndrome (aHUS) is caused by complement dysregulation and is generally diagnosed by exclusion from other disorders of thrombotic microangiopathy (TMA). Eculizumab, a terminal compleme...

    Authors: Hideo Wada, Hirofumi Teranishi, Akihiko Shimono, Noritoshi Kato, Shoichi Maruyama and Masanori Matsumoto
    Citation: Thrombosis Journal 2023 21:43
    Content type: Research Published on:

  14. Patients with critical illness due to COVID-19 exhibit increased coagulability associated with a high risk of venous thrombo-embolism (VTE). Data on prophylactic anticoagulation for these patients are limited ...

    Authors: Pauline Lamouche-Wilquin, Léa Perrin, Morgane Pere, Matthieu Raymond, Pierre Asfar, Cedric Darreau, Florian Reizine, Gwenhaël Colin, Agathe Delbove, Johann Auchabie, Baptiste Hourmant, Aurélien Frérou, Béatrice La Combe, Jean Morin, Pierre Kergoat, Julien Lorber…
    Citation: Thrombosis Journal 2023 21:42
    Content type: Research Published on:

  15. Blood transfusion and previous stroke history are two independent risk factors of venous thromboembolism (VTE) in stroke patients. Whether the potential interaction of transfusion history and previous stroke h...

    Authors: Changqing Sun, Rongrong Wang, Lianke Wang, Panpan Wang, Ying Qin, Qianyu Zhou, Yuanli Guo, Mingyang Zhao, Wenqian He, Bo Hu, Zihui Yao, Peijia Zhang, Tiantian Wu, Yu Wang and Qiang Zhang
    Citation: Thrombosis Journal 2023 21:41
    Content type: Research Published on:

  16. Experimental studies suggested that intercellular adhesion molecule 4 (ICAM-4) might be implicated in ischemic stroke, but the population-based evidence on the relationship between ICAM-4 and ischemic stroke w...

    Authors: Lulu Sun, Daoxia Guo, Yiming Jia, Mengyao Shi, Pinni Yang, Yu Wang, Fanghua Liu, Zhengbao Zhu and Jin Zheng
    Citation: Thrombosis Journal 2023 21:40
    Content type: Research Published on:

  17. Acute mesenteric ischemia (AMI) is a life-threatening condition with a high mortality rate. The standard practice after making the diagnosis includes aggressive resuscitation, anticoagulation, followed by reva...

    Authors: Yuqian Tian, Sanjeev Dhara, Christopher D. Barrett, Aaron P. Richman and Tejal S. Brahmbhatt
    Citation: Thrombosis Journal 2023 21:39
    Content type: Review Published on:

  18. Post-thrombotic syndrome (PTS) is a complication of deep vein thrombosis (DVT) and affects 20–40% of DVT subjects. The risk factor of PTS after DVT is difficult to determine. We aimed to evaluate the incidence...

    Authors: Farieda Ariyanti, Lugyanti Sukrisman, Dono Antono and Kuntjoro Harimurti
    Citation: Thrombosis Journal 2023 21:38
    Content type: Research Published on:

  19. Based on the few available studies on the prognostic benefit of using direct oral anticoagulants (DOACs) after atrial fibrillation (AF) ablation. Therefore, this study aimed to evaluate the prognostic differen...

    Authors: Shuyi Wu, Chengfu Guan, Wenlin Xu, Feilong Zhang, Nianxu Huang, Xia Chen, Wang Zhang, Wei Hu, Jun Su, Hengfen Dai, Ping Gu, Xiaohong Huang, Xiaoming Du, Ruijuan Li, Qiaowei Zheng, Xiangsheng Lin…
    Citation: Thrombosis Journal 2023 21:37
    Content type: Research Published on:

  20. Microwave ablation (MWA) via ultrasound guidance is an important tool in the treatment of liver metastases. The most common postoperative complications are abdominal hemorrhage and bile leakage, whereas thromb...

    Authors: Jun Ma, Juan Zhu, Tengyun Ding, Libin Cai, Chaoping Zhou and Yaming Zhang
    Citation: Thrombosis Journal 2023 21:36
    Content type: Case Report Published on:

  21. Liver disease is any condition that affects the liver cells and their function. It is directly linked to coagulation disorders since most coagulation factors are produced by the liver. Therefore, this study ai...

    Authors: Abateneh Melkamu, Berhanu Woldu, Chomaw Sitotaw, Masresha Seyoum and Melak Aynalem
    Citation: Thrombosis Journal 2023 21:35
    Content type: Research Published on:

  22. The present study aimed to investigate the prevalence, predictors, and management of left atrial appendage (LAA) thrombogenic milieu (TM) identified with transesophageal echocardiography (TEE) in non-valvular ...

    Authors: Yu Qiao, Zhen Zhao, Xiang Cai, Yulong Guo, Ke Liu, Jinrui Guo, Tao Guo and Guodong Niu
    Citation: Thrombosis Journal 2023 21:34
    Content type: Research Published on:

  23. Pulmonary tumor thrombotic microangiopathy (PTTM) is a rare malignancy-related respiratory complication, demonstrating rapid progression of pulmonary hypertension (PH) and respiratory failure. Although a numbe...

    Authors: Yang Wang, Wei-wei Ning, Yi-fan Jin, Qing-qing Zhu, Zai-liang Wang, Nan Su, Yan-bin Chen, Jian-an Huang and Cheng Chen
    Citation: Thrombosis Journal 2023 21:33
    Content type: Case Report Published on:

  24. Current guidelines recommend extending the use of dual antiplatelet therapy (DAPT) beyond 1 year in patients with an acute coronary syndrome (ACS) and a high risk of ischaemia and low risk of bleeding. No data...

    Authors: Albert Ariza-Solé, Gemma Mateus-Porta, Francesc Formiga, Sergio Garcia-Blas, Clara Bonanad, Iván Núñez-Gil, Carlos Vergara-Uzcategui, Pablo Díez-Villanueva, Jordi Bañeras, Clara Badia-Molins, Jaime Aboal, José Carreras-Mora, Ana Gabaldón-Pérez, José Antonio Parada-Barcia, Manuel Martínez-Sellés, Josep Comín-Colet…
    Citation: Thrombosis Journal 2023 21:32
    Content type: Research Published on:

  26. Venous thromboembolism (VTE) including Deep Venous Thrombosis (DVT) and Pulmonary Embolism (PE), is a serious cause of patient morbidity and mortality in hospitals. Neurosurgical hospitalized patients have hig...

    Authors: Pan Lin, James Allen Wiley, Lingyun Tian, Wan Li, Qiuhong Yang, Haifan Yang, Xin Tan, Yijing Gao, Weijuan Li, Hui Luo, Xinyu Feng and Yinglan Li
    Citation: Thrombosis Journal 2023 21:30
    Content type: Research Published on:

  27. Cronkhite-Canada syndrome (CCS) is a rare disease characterized by generalized gastrointestinal polyps, ectodermal abnormalities and variable gastrointestinal symptoms. Few cases to date have described complic...

    Authors: Xiao-Kai Feng, Xiao-Fen Chen, Bei-Bei Wang, Zhi-Gang Zeng, Chao Liu, Wei-Hong Sha and Juan Ma
    Citation: Thrombosis Journal 2023 21:29
    Content type: Case Report Published on:

  28. Risk prediction rules are important to establish appropriate treatment and management strategy for patients with different risk classification of pulmonary embolism (PE). Neutrophils are considered to be relat...

    Authors: Rui Peng, Weihua Yin, Fang Wang, Xiangfeng Cong, Bin Lu, Lu Hua and Xi Chen
    Citation: Thrombosis Journal 2023 21:28
    Content type: Research Published on:

  29. Thrombolysis-related intracranial hemorrhage has a high mortality rate, and many factors can cause intracranial hemorrhage. Until now, systematic reviews and assessments of the certainty of the evidence have n...

    Authors: Jiana Chen, Zhiwei Zeng, Zongwei Fang, Fuxin Ma, Meina Lv and Jinhua Zhang
    Citation: Thrombosis Journal 2023 21:27
    Content type: Research Published on:

  30. Transplantation-associated thrombotic microangiopathy (TA-TMA) is an endothelial injury syndrome linked to the overactivation of complement pathways. It manifests with microangiopathic hemolytic anemia, consum...

    Authors: Ambreen Pandrowala, Parth Ganatra, V. P. Krishnan, Ajay Narayan Sharma, Saroj Chavan, Minnie Bodhanwala, Bharat Agarwal and Prashant Hiwarkar
    Citation: Thrombosis Journal 2023 21:26
    Content type: Case Report Published on:

  31. The present study aimed to investigate the preliminary safety and efficacy of rheolytic thrombectomy (RT) using an AngioJet Zelante DVT catheter or a Solent Omni catheter for acute proximal deep vein thrombosi...

    Authors: Maofeng Gong, Guanqi Fu, Zhengli Liu, Yangyi Zhou, Jie Kong, Boxiang Zhao, Wensheng Lou, Jianping Gu and Xu He
    Citation: Thrombosis Journal 2023 21:25
    Content type: Research Published on:

  32. It has been shown that long non-coding RNA (lncRNA) LINC00659 was markedly upregulated in the peripheral blood of patients with deep venous thrombosis (DVT). However, the function of LINC00659 in lower extremi...

    Authors: Bo Zhang and Jie Qin
    Citation: Thrombosis Journal 2023 21:24
    Content type: Research Published on:

  33. The use of viscoelastic tests is becoming increasingly popular. There is a paucity of validation of the reproducibility of varying coagulation states. Therefore, we aimed to study the coefficient of variation ...

    Authors: Lotta Sunnersjö, Henrik Lindström, Ulf Schött, Noa Törnquist and Thomas Kander
    Citation: Thrombosis Journal 2023 21:23
    Content type: Research Published on:

  34. To investigate venous thromboembolism (VTE) in hospitalized patients with severe high altitude pulmonary edema (HAPE), we performed a single center retrospective study to evaluate its clinical characteristics,...

    Authors: Yanmin Liu, Xinwei Feng, Yongxue Tang, Yanqiu Sun, Xiaoyan Pu and Xiaokai Feng
    Citation: Thrombosis Journal 2023 21:22
    Content type: Research Published on:

  35. Anti-factor Xa assays and activated partial thromboplastin time (aPTT) are mainly employed to monitor patients treated with heparins. According to the Clinical and Laboratory Standards Institute and the French...

    Authors: Marion Gremillet, Laurie Talon, Aurélien Lebreton and Thomas Sinegre
    Citation: Thrombosis Journal 2023 21:21
    Content type: Research Published on:

  36. Hypocalcemia has been shown to be involved in the adverse outcomes of acute pulmonary embolism (APE). We aimed to determine the incremental value of adding hypocalcemia, defined as serum calcium level ≤ 2.12 m...

    Authors: Jiarui Zhang, Adila Ali, Yu Liu, Lige Peng, Jiaqi Pu, Qun Yi and Haixia Zhou
    Citation: Thrombosis Journal 2023 21:20
    Content type: Research Published on:

  38. Integrins are heterodimeric receptors comprising α and β subunits. They are expressed on the cell surface and play key roles in cell adhesion, migration, and growth. Several types of integrins are expressed on...

    Authors: Honglei Xin, Jiansong Huang, Zhiqun Song, Jianhua Mao, Xiaodong Xi and Xiaofeng Shi
    Citation: Thrombosis Journal 2023 21:18
    Content type: Review Published on:

  39. Studies on the incidence of venous thromboembolism (VTE) events in patients with interstitial lung disease (ILD) are limited and the results are inconsistent. The aim of this research was to investigate the in...

    Authors: Haishuang Sun, Min Liu, Xiaoyan Yang, Linfeng Xi, Wenqing Xu, Mei Deng, Yanhong Ren, Wanmu Xie, Huaping Dai and Chen Wang
    Citation: Thrombosis Journal 2023 21:17
    Content type: Research Published on:

  40. Data that guide selection of differing anticoagulant regimens for specific cancer-associated venous thromboembolism (VTE) are lacking. We aimed to compare the efficacy and safety of rivaroxaban and low-molecul...

    Authors: Yijun Song, Dawei Yang, Dongni Hou, Jun She and Yuanlin Song
    Citation: Thrombosis Journal 2023 21:16
    Content type: Research Published on:

  41. The optimal duration and choice of anticoagulant for the treatment of Peripherally inserted central catheters (PICC)-related upper extremity deep vein thrombosis (UEDVT) in cancer patients are still undetermined.

    Authors: Jiaxuan Xu, Guodong Wang, Xiaojie Chen, Yanfen Shen, Xinpeng Wang and Hongzhi Wang
    Citation: Thrombosis Journal 2023 21:15
    Content type: Research Published on:

  42. Coronavirus disease 2019 (COVID-19) is associated with provoked thrombo-inflammatory responses. Early in the COVID-19 pandemic this was thought to contribute to hypercoagulability and multi-organ system compli...

    Authors: Mohamed S. Zaghloul, Momodou Jammeh, Andrew Gibson, Suhong Luo, Kelley Chadwick-Mansker, Qianjin Liu, Yan Yan and Mohamed A. Zayed
    Citation: Thrombosis Journal 2023 21:14
    Content type: Research Published on:

  43. The role of anticoagulants in the treatment of cirrhotic PVT remains controversial. This study aimed to analyze the safety and efficacy of anticoagulant therapy in patients with cirrhotic portal vein thrombosi...

    Authors: Zhiqi Zhang, Ying Zhao, Dandan Li, Mingxing Guo, Hongyu Li, Ranjia Liu and Xiangli Cui
    Citation: Thrombosis Journal 2023 21:13
    Content type: Research Published on:

  44. The hyper-coagulopathy nature of COVID-19 is a prevalent consequence among patients. Free-floating right atrial thrombi are a relatively rare finding and the optimal therapy is a therapeutic dilemma.

    Authors: Mahsa Mahjani, Sepehr Gohari and Hassan Ahangar
    Citation: Thrombosis Journal 2023 21:12
    Content type: Case Report Published on:

  45. Extracorporeal membrane oxygenation (ECMO) can provide life-saving support for critically ill patients suffering severe respiratory and/or cardiac failure. However, thrombosis and bleeding remain common and co...

    Authors: Saeedreza Zeibi Shirejini, Josie Carberry, Zoe K. McQuilten, Aidan J. C. Burrell, Shaun D. Gregory and Christoph E. Hagemeyer
    Citation: Thrombosis Journal 2023 21:11
    Content type: Review Published on:

  46. Tranexamic acid (TXA) is an antifibrinolytic drug that blocks lysine-binding sites on the profibrinolytic enzyme plasminogen. Aortic diseases with chronic consumption coagulopathy may lead to disseminated intr...

    Authors: Naruko Suzuki, Nobuaki Suzuki, Yuka Kawaguchi, Shuichi Okamoto, Takeshi Kanematsu, Akira Katsumi, Atsuo Suzuki, Shogo Tamura, Tetsuhito Kojima, Hitoshi Kiyoi and Tadashi Matsushita
    Citation: Thrombosis Journal 2023 21:10
    Content type: Research Published on:

  47. Portal vein thrombosis is a common complication of liver cirrhosis and hepatocellular carcinoma; however, few studies have reported its long-term clinical prognosis. This study aimed to establish and validate ...

    Authors: Xuan Zhong, Shan Li, Jiali Hu, Jinlai Lu, Wei Wang, Miao Hu, Qinjuan Sun, Shuo Zhang, Xiaoqing Yang, Changqing Yang and Lan Zhong
    Citation: Thrombosis Journal 2023 21:9
    Content type: Research Published on:

  48. The assessment of VTE likelihood with VTE risk scores is essential prior to imaging examinations during VTE diagnostic procedure. Little is known with respect to the disparity of predictive power for VTE diagn...

    Authors: Wei Xiong, Yunfeng Zhao, Yi Cheng, He Du, Jinyuan Sun, Yanmin Wang, Mei Xu and Xuejun Guo
    Citation: Thrombosis Journal 2023 21:8
    Content type: Research Published on:

  49. Several prior studies postulated an effect of hypertension on coagulation factors. However, population-based studies investigating the sex-specific associations between hypertension and hemostatic parameters a...

    Authors: J. Vogel von Falckenstein, D. Freuer, A. Peters, M. Heier, J. Linseisen and C. Meisinger
    Citation: Thrombosis Journal 2023 21:7
    Content type: Research Published on:

  50. Cavernous transformation of the portal vein (CTPV) in cirrhotic patients with extrahepatic portal vein obstruction (EHPVO) was a relatively rare disease and had no consensus on the treatment. Our study aimed t...

    Authors: Yongjie Zhou, Zhiquan Zhuang, Tianzhu Yu, Wen Zhang, Jingqin Ma, Jiaze Yu, Zhiping Yan and Jianjun Luo
    Citation: Thrombosis Journal 2023 21:6
    Content type: Research Published on:
Submit manuscript

Official journal of

  • APSTH logo

  • Thrombosis Journal is the official journal of the Asian-Pacific Society on Thrombosis and Hemostasis.

Follow

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 2.6
    5-year Journal Impact Factor: 3.1
    Source Normalized Impact per Paper (SNIP): 0.653
    SCImago Journal Rank (SJR): 0.572

    Speed 2023
    Submission to first editorial decision (median days): 11
    Submission to acceptance (median days): 107

    Usage 2023
    Downloads: 708,004
    Altmetric mentions: 943

Thrombosis Journal

ISSN: 1477-9560

Contact us